Jethwa Jashan, Ireland Robert S, Chan David
Warwick Medical School, University of Warwick, Coventry, UK.
J Investig Clin Dent. 2019 May;10(2):e12397. doi: 10.1111/jicd.12397. Epub 2019 Jan 17.
The aim of the present study was to investigate whether a combination of platelet-rich plasma (PRP) and decalcified freeze-dried bone allograft (DFDBA) offers advantages over DFDBA and saline in infrabony defects. The objectives were to primarily evaluate changes in clinical attachment level (CAL) and secondarily changes in pocket depth (PD). A search was performed of electronic databases (Medline, PubMed, Embase, The Cochrane Central Register of Controlled Trials, and Web of Science), as well as hand searching and reference list searching. Only randomized, controlled trials published up until 30 March 2018 were included that had a follow-up period of at least 6 months. Four papers met the eligibility criteria and were critically appraised using the Consolidated Standards of Reporting Trials statement and put through the Cochrane Collaboration's tool for assessing risk of bias. In three of the four studies, clinically and significantly greater CAL gains and PD reductions were observed in patients who received PRP and DFDBA in comparison to those who received DFDBA and saline (P < 0.05). Methodological heterogeneity existed among the studies, especially in the preparation of PRP and the type of infrabony defect. This made it difficult to draw clear conclusions, but despite this, the studies could still be regarded, as significant as they showed a low risk of bias.
本研究的目的是调查富血小板血浆(PRP)与脱钙冻干骨同种异体移植物(DFDBA)联合应用在骨下袋缺损治疗中是否比DFDBA和生理盐水具有优势。主要目标是评估临床附着水平(CAL)的变化,次要目标是评估牙周袋深度(PD)的变化。我们检索了电子数据库(Medline、PubMed、Embase、Cochrane对照试验中央注册库和Web of Science),并进行了手工检索和参考文献列表检索。仅纳入截至2018年3月30日发表的随访期至少为6个月的随机对照试验。有四篇论文符合纳入标准,并根据报告试验的统一标准声明进行了严格评估,并通过Cochrane协作网的偏倚风险评估工具进行分析。在四项研究中的三项研究中,与接受DFDBA和生理盐水的患者相比,接受PRP和DFDBA的患者在临床上观察到显著更大的CAL增加和PD减少(P<0.05)。研究之间存在方法学异质性,尤其是在PRP的制备和骨下袋缺损的类型方面。这使得难以得出明确的结论,但尽管如此,这些研究仍可被视为具有重要意义,因为它们显示出较低的偏倚风险。